Tracer could indicate radiation benefit to patient

June 3, 2014 by Chris Thomas
The study aims to use robust methodology to quantify how beneficial radiation is for patients, and how long they feel better after receiving it. Credit: Urology San Antonio

A world-first radiotherapy treatment trial by University of WA researchers could have a major impact on the quality of life for mesothelioma patients.

Funded by an almost $100,000 Cancer Council WA grant, the research team is exploring why some respond to radiotherapy treatment while others don't, as well as developing tests to predict whether patients will respond to avoid people being treated unnecessarily.

Lead researcher Professor Anna Nowak says there have been several retrospective studies and case series that suggest radiotherapy shrinks tumour and improves pain—but only as measured by clinicians.

"No previous study has given a uniform dose of radiotherapy and used patient-rated measures such as pain scores, pain medication doses and quality of life questionnaires as recorded by the patient to quantify the benefits patients actually experience," she says.

"We know there can be differences between seeing a tumour shrink on scans and whether the patient actually feels better after treatment.

"Nobody has previously used robust methodology to quantify what the magnitude of benefit is, what proportion of patients feel better and how long they feel better for."

While radiotherapy is widely used in mesothelioma treatment, there are no known predictors of responsiveness.

But when used for treating other cancers, measuring the (low oxygen levels in a tumour) can give an indication of how well patients might respond.

Measuring tumour oxygen to gauge radiation response

Professor Nowak's team plans to use an imaging technique to examine hypoxia levels within tumours.

"Radiotherapy needs an oxygenated environment to cause cell death in cancers through DNA damage," she says.

"F-Misonidazole, or F-MISO, is a radioactively labelled tracer which is injected into the patient about two hours before a PET [] scan.

"In hypoxic cells, F-MISO goes into the cell and remains trapped because there is no oxygen to regenerate it.

"Our hypothesis is the tumours with the strongest uptake of F-MISO [the most hypoxia] will be those in which patients derive less benefit—less reduction in pain and medication, less improvement in quality of life and less tumour shrinkage on CT scans after radiotherapy."

If F-MISO scans can predict response to radiotherapy, Professor Nowak says it could become a standard test before recommending radiotherapy to patients, allowing them to be better informed about the likelihood of its benefit.

And if hypoxia proves to be a predictor of poor response to , strategies to reverse or improve hypoxia could be studied.

"We are already testing some of these in mice," Profe Nowak says.

"Simple possible strategies may even include blood transfusions, high-flow oxygen or medications currently used to improve blood flow to the heart."

Explore further: Oxygen levels in tumours affect response to treatment

Related Stories

Oxygen levels in tumours affect response to treatment

November 7, 2013
(Medical Xpress)—The genetic make-up of a patient's tumour could be used to personalise their treatment, and help to decide whether they would benefit from receiving additional drugs as part of their radiotherapy programme, ...

New agent may enhance effectiveness of radiotherapy

May 13, 2014
Scientists from The University of Manchester – part of the Manchester Cancer Research Centre - have demonstrated the potential of a drug to improve the effectiveness of radiotherapy in stopping tumour growth.

Researchers use new simple cost effective technology to unravel cancer through standard imaging

June 3, 2014
Researchers at Maastricht University Medical Center+ (Maastricht UMC+) and the MAASTRO Clinic have developed a new medical imaging analysis method to predict the risk of dying of cancer in patients. For the first time, they ...

New test developed to detect men at high risk of prostate cancer recurrence

April 5, 2014
Vienna, Austria: A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference ...

Radiotherapy could spare bladder cancer patients surgery

October 1, 2013
Radiotherapy is an effective treatment for aggressive bladder cancer and could spare patients surgery that removes the whole bladder, according to a study published in this month's International Journal of Radiation Oncology ...

Hypnosis therapy shown to decrease fatigue levels in breast cancer patients

February 20, 2014
Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis (CBTH), according to a study recently published in the Journal of Clinical Oncology.

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.